Ubs Group Ag Igm Biosciences, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 7,204 shares of IGMS stock, worth $59,216. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,204

Previous 8,407 14.31%

Holding current value

$59,216

Previous $57,000 108.77%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.28 - $17.68 $7,554 - $21,269	-1,203 Reduced 14.31%	7,204 $119,000
Q2 2024 Aug 13, 2024	SELL	$6.51 - $11.47 $32,055 - $56,478	-4,924 Reduced 36.94%	8,407 $57,000
Q1 2024 May 13, 2024	BUY	$8.68 - $17.36 $1,137 - $2,274	131 Added 0.99%	13,331 $128,000
Q4 2023 Feb 09, 2024	BUY	$3.94 - $8.79 $24,424 - $54,489	6,199 Added 88.54%	13,200 $109,000
Q3 2023 Nov 09, 2023	SELL	$6.66 - $10.64 $6,360 - $10,161	-955 Reduced 12.0%	7,001 $58,000
Q2 2023 Aug 11, 2023	BUY	$8.86 - $14.0 $27,891 - $44,072	3,148 Added 65.47%	7,956 $73,000
Q1 2023 May 12, 2023	BUY	$13.74 - $25.76 $11,679 - $21,896	850 Added 21.48%	4,808 $66,000
Q4 2022 Feb 08, 2023	BUY	$15.45 - $26.02 $57,443 - $96,742	3,718 Added 1549.17%	3,958 $67,000
Q3 2022 Nov 10, 2022	SELL	$15.42 - $27.01 $9,190 - $16,097	-596 Reduced 71.29%	240 $5,000
Q2 2022 Aug 10, 2022	SELL	$13.27 - $25.5 $3,410 - $6,553	-257 Reduced 23.51%	836 $15,000
Q1 2022 May 16, 2022	SELL	$13.42 - $29.73 $691,881 - $1.53 Million	-51,556 Reduced 97.92%	1,093 $29,000
Q4 2021 Feb 14, 2022	BUY	$27.59 - $66.39 $494,081 - $1.19 Million	17,908 Added 51.55%	52,649 $1.55 Million
Q3 2021 Nov 15, 2021	BUY	$65.76 - $90.65 $2.02 Million - $2.79 Million	30,739 Added 768.09%	34,741 $2.28 Million
Q2 2021 Aug 13, 2021	SELL	$57.98 - $96.6 $710,776 - $1.18 Million	-12,259 Reduced 75.39%	4,002 $333,000
Q1 2021 May 12, 2021	BUY	$71.56 - $121.23 $1.15 Million - $1.95 Million	16,087 Added 9245.4%	16,261 $1.25 Million
Q4 2020 Feb 11, 2021	SELL	$47.41 - $115.03 $255,587 - $620,126	-5,391 Reduced 96.87%	174 $15,000
Q3 2020 Nov 12, 2020	BUY	$43.0 - $84.01 $224,890 - $439,372	5,230 Added 1561.19%	5,565 $411,000
Q2 2020 Jul 31, 2020	SELL	$51.3 - $75.21 $136,817 - $200,585	-2,667 Reduced 88.84%	335 $24,000
Q1 2020 May 01, 2020	SELL	$31.51 - $73.75 $130,987 - $306,578	-4,157 Reduced 58.07%	3,002 $169,000
Q4 2019 Feb 14, 2020	BUY	$17.25 - $49.51 $123,492 - $354,442	7,159 New	7,159 $273,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $238M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account